SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-191839
Filing Date
2023-07-24
Accepted
2023-07-24 07:16:07
Documents
36
Period of Report
2023-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d542769d8k.htm   iXBRL 8-K 47151
2 EX-2.1 d542769dex21.htm EX-2.1 507964
3 EX-99.1 d542769dex991.htm EX-99.1 23346
4 EX-99.2 d542769dex992.htm EX-99.2 39649
9 GRAPHIC g542769ex99_1p10g1.jpg GRAPHIC 268086
10 GRAPHIC g542769ex99_1p11g1.jpg GRAPHIC 276151
11 GRAPHIC g542769ex99_1p12g1.jpg GRAPHIC 311945
12 GRAPHIC g542769ex99_1p13g1.jpg GRAPHIC 303617
13 GRAPHIC g542769ex99_1p14g1.jpg GRAPHIC 355204
14 GRAPHIC g542769ex99_1p15g1.jpg GRAPHIC 368488
15 GRAPHIC g542769ex99_1p16g1.jpg GRAPHIC 387825
16 GRAPHIC g542769ex99_1p17g1.jpg GRAPHIC 351381
17 GRAPHIC g542769ex99_1p18g1.jpg GRAPHIC 392624
18 GRAPHIC g542769ex99_1p19g1.jpg GRAPHIC 443568
19 GRAPHIC g542769ex99_1p1g1.jpg GRAPHIC 230637
20 GRAPHIC g542769ex99_1p2g1.jpg GRAPHIC 621629
21 GRAPHIC g542769ex99_1p3g1.jpg GRAPHIC 443306
22 GRAPHIC g542769ex99_1p4g1.jpg GRAPHIC 385578
23 GRAPHIC g542769ex99_1p5g1.jpg GRAPHIC 370573
24 GRAPHIC g542769ex99_1p6g1.jpg GRAPHIC 324390
25 GRAPHIC g542769ex99_1p7g1.jpg GRAPHIC 372416
26 GRAPHIC g542769ex99_1p8g1.jpg GRAPHIC 390250
27 GRAPHIC g542769ex99_1p9g1.jpg GRAPHIC 426807
28 GRAPHIC g542769g34g51.jpg GRAPHIC 5756
  Complete submission text file 0001193125-23-191839.txt   10619448

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA qncx-20230721.xsd EX-101.SCH 3881
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qncx-20230721_def.xml EX-101.DEF 13697
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE qncx-20230721_lab.xml EX-101.LAB 22683
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qncx-20230721_pre.xml EX-101.PRE 14665
30 EXTRACTED XBRL INSTANCE DOCUMENT d542769d8k_htm.xml XML 5155
Mailing Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38890 | Film No.: 231103739
SIC: 2836 Biological Products, (No Diagnostic Substances)